MARKET

HALO

HALO

Halozyme Thrp
NASDAQ
63.33
+0.38
+0.60%
After Hours: 64.25 +0.92 +1.45% 19:55 12/05 EST
OPEN
62.81
PREV CLOSE
62.95
HIGH
63.98
LOW
62.59
VOLUME
1.55M
TURNOVER
--
52 WEEK HIGH
79.50
52 WEEK LOW
46.26
MARKET CAP
7.45B
P/E (TTM)
13.32
1D
5D
1M
3M
1Y
5Y
1D
The Healthcare Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar.
The Motley Fool · 16h ago
Buy/Sell: Wall Street’s top 10 stock calls this week
TipRanks · 1d ago
Taking Stock of Halozyme Therapeutics (HALO) Valuation After Zacks Upgrade and Raised Full‑Year Guidance
Simply Wall St · 1d ago
Analysts Offer Insights on Healthcare Companies: MapLight Therapeutics, Inc. (MPLT) and Halozyme (HALO)
TipRanks · 1d ago
Correction to Halozyme Granted Injunction Against Merck & Co. Article
Dow Jones · 2d ago
Halozyme granted injunction in Germany barring Merck's subcutaneous Keytruda
Seeking Alpha · 2d ago
Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case
Dow Jones · 2d ago
*Halozyme: German Proceedings Part of Global Enforcement of MDASE Patents Against Infringement by Keytruda SC
Dow Jones · 2d ago
More
About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing solutions to improve patient experiences and outcomes for emerging and established therapies. The Company's commercially-validated solution, ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, is used to facilitate the subcutaneous delivery of injected drugs and fluids, with a focus on improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine ENHANZE with its partners’ proprietary compounds. It also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The Company has two commercial proprietary products, Hylenex and XYOSTED. It also has a proprietary ultra-high concentration microparticle formulation technology for biologics, branded Hypercon.

Webull offers Halozyme Therapeutics, Inc. stock information, including NASDAQ: HALO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HALO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HALO stock methods without spending real money on the virtual paper trading platform.